The aim of this trial was to compare short-term efficacy of an alginate (Gaviscon®, 4 × 10 mL/day) and omeprazole (20 mg/day) on GERD symptoms in general practice. Methods A 14-day multicentre ...

However, alginate solutions may also have a therapeutic action via oesophageal mucosal protection properties. We tested the ability of topically applied Gaviscon Double Action to reduce impairment of ...

Know the news with the 7NEWS app: Download today Reckitt Benckiser, the company that makes Gaviscon, confirmed the shortage in a statement to 7EWS.com.au “Unfortunately, we’re experiencing a shortage ...

Omeprazole in symptOmatic treatment of moDerate gastroesophageal reflux" (GOOD), the aim of which was to compare short-term symptomatic efficacy and safety between an alginate (Gaviscon®, 4 × 10 ...